On Monday, the stock of Avanor Pharmaceuticals, a drug company that makes a drug for epilepsy, lost its value by more than $30 per share.In the days after the stock fell, investors took note of Ava’s poor performance, which included a poor quarterly earnings report and an acquisition of the company’s medical device business.Since then, […]

Continue Reading...